查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2056340

寵物癌症治療市場報告：治療方法、動物種類、癌症類型、最終用戶和地區分類（2026-2034 年）

Pet Cancer Therapeutics Market Report by Therapy, Animal Species, Cancer Type, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球寵物癌症治療市場規模達3.459億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到6.887億美元，2026年至2034年的複合年成長率為7.71%。推動市場成長的主要因素包括寵物飼養量的增加、人與動物之間情感紐帶的加深、獸醫學和研究的進步，以及人們對寵物癌症治療的可及性和益處的認知不斷提高。

獸醫癌症治療是指專門用於診斷、治療和控制動物（尤其是犬貓）癌症的醫療程序和藥物。與人類癌症治療類似，這些治療方法包括化療、放射線治療、免疫療法、標靶治療和安寧療護。獸醫腫瘤學家運用這些治療方法來治療寵物的各種癌症，並提高它們的生命品質。隨著獸醫學的不斷進步，獸醫癌症治療方法的普及性和有效性也在不斷提高，從而確保飼主能夠為被診斷患有癌症的愛寵提供全面而充滿關懷的護理。

寵物數量的增加以及人與動物之間日益加深的情感紐帶，正在推動預測期內市場成長。飼主更願意投資於包括癌症治療在內的先進療法，以確保愛寵的健康和福祉。此外，由於診斷能力的提高和寵物壽命的延長，寵物癌症發生率的上升也增加了對有效且專業的治療方法的需求。同時，獸醫腫瘤學和研究領域的許多進展，例如針對寵物開發更具標靶性和創新性的癌症治療方法，也正在促進市場成長。此外，飼主對寵物癌症治療的可用性和益處的認知不斷提高，促使癌症能夠更早被發現和早期療育，從而進一步推動市場成長。此外，專業獸醫腫瘤中心的建立以及獸醫腫瘤學家與人類癌症專家之間合作的加強，正在改善寵物癌症治療的可及性和專業水平，從而促進市場成長。

寵物癌症藥物市場的發展趨勢與促進因素：

寵物數量的增加以及人與動物之間關係的加強

寵物數量的不斷成長以及人類與動物之間日益緊密的聯繫，是推動寵物癌症治療市場發展的重要因素。隨著越來越多的家庭將寵物視為家庭成員，這些伴侶動物也越來越被視為備受寵愛的家人。這種情感連結促使飼主肩負起確保愛寵健康福祉的重任。因此，飼主越來越願意投資先進的癌症治療，以對抗寵物的疾病並提高它們的生命品質。寵物飼主渴望為心愛的寵物提供最好的照顧，這導致對能夠減輕寵物痛苦並延長其壽命的有效癌症治療的需求不斷成長。

獸醫腫瘤學進展

近年來，由於技術進步和研究的顯著進展，獸醫腫瘤學領域取得了令人矚目的成就。診斷技術的改進使得癌症的早期精準檢測成為可能，讓獸醫能夠及時啟動治療。此外，對寵物癌症生物學的深入了解也為標靶治療、免疫療法和新型治療方法的開發鋪平了道路。獸醫腫瘤學家現在可以擴大癌症治療的選擇範圍，並根據每隻寵物的具體情況制定個人化的治療方案。這些進展為面臨癌症診斷的飼主帶來了希望，並鼓勵他們探索和選擇先進且有效的癌症治療方法。

獸醫保健成本不斷上漲

隨著人們對寵物的認知從單純的伴侶動物轉變為珍愛的家庭成員，獸醫保健支出模式也發生了顯著變化。如今的飼主比以往任何時候都更願意投資，以確保寵物的健康和長壽。人們對現有癌症治療方法的了解不斷加深，並渴望為寵物提供最佳的護理，這推動了寵物癌症治療支出的成長。飼主願意投資最新、最有效的癌症療法，以對抗疾病，改善愛寵的整體健康。獸醫保健支出的激增進一步推動了寵物癌症治療市場的發展，並為寵物癌症治療的研究、創新和先進治療方法的研發創造了機會。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：寵物癌症治療藥物的全球市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依療法分類

  • 化療
  • 放射線治療
  • 免疫療法
  • 聯合治療
  • 其他

第7章 市場區隔：依動物種類分類

  • 貓
  • 狗
  • 其他

第8章 市場區隔：依癌症類型分類

  • 淋巴瘤
  • 肥大細胞癌
  • 黑色素瘤
  • 乳癌和鱗狀細胞癌
  • 其他

第9章 市場區隔：依最終用戶分類

  • 獸醫醫院和臨床藥房
  • 零售藥房
  • 網路藥房
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • AB Science
    • Boehringer Ingelheim International GmbH
    • Elanco Animal Health Incorporated
    • ELIAS Animal Health LLC
    • Karyopharm Therapeutics
    • Pfizer Inc.
    • Regeneus Ltd.
    • Rhizen Pharmaceuticals AG
    • Torigen Pharmaceuticals Inc.
    • VetDC Inc.
    • Virbac
    • Zoetis Inc.
Product Code: SR112026A4472

The global pet cancer therapeutics market size reached USD 345.9 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 688.7 Million by 2034, exhibiting a growth rate (CAGR) of 7.71% during 2026-2034. The increasing pet ownership rates and human-animal bond, advancements in veterinary medicine and research, and growing awareness about the availability and benefits of pet cancer therapeutics are some of the major factors propelling the market.

Pet cancer therapeutics are specialized medical treatments and drugs designed to diagnose, treat, and manage cancer in animals, particularly in dogs and cats. Similar to cancer treatments in humans, these therapeutics may include chemotherapy, radiation therapy, immunotherapy, targeted therapies, and palliative care. Veterinary oncologists administer these therapies to address various types of cancer in pets and improve their quality of life. As advancements in veterinary medicine continue, the availability and effectiveness of pet cancer therapeutics have increased, allowing pet owners to access comprehensive and compassionate care for their beloved animal companions diagnosed with cancer.

The rising willingness among pet owners to invest in advanced medical treatments, including cancer therapeutics, to ensure the well-being of their animal companions due to the increasing pet ownership and human-animal bond, will stimulate the growth of the market during the forecast period. Moreover, the growing prevalence of cancer in pets, owing to improved diagnostic capabilities and prolonged lifespan has augmented the demand for effective and specialized treatments. Apart from this, numerous advancements in veterinary oncology and research, including the development of more targeted and innovative cancer therapies for pets, have catalyzed the market growth. Additionally, the heightening awareness among pet owners about the availability and benefits of pet cancer therapeutics has led to early detection and intervention, propelling the market growth. Furthermore, the establishment of specialized veterinary oncology centers and the rising collaborations between veterinary and human oncologists that improve the accessibility and expertise in pet cancer care are contributing to the market growth.

Pet Cancer Therapeutics Market Trends/Drivers:

Increasing pet ownership and human-animal bond

The rise in pet ownership and the strengthening human-animal bond have become significant drivers in the market for pet cancer therapeutics. As more households welcome pets into their lives, these companion animals are widely considered cherished family members. This emotional connection fosters a deep sense of responsibility among pet owners to ensure the well-being and health of their furry companions. Consequently, there is a growing willingness among pet owners to invest in advanced cancer treatments to combat the disease and enhance the quality of life for pets. Pet owners seek the best possible care for their pets, leading to an increased demand for effective cancer therapeutics that can alleviate suffering and prolong their pets' lives.

Advancements in veterinary oncology

The field of veterinary oncology has witnessed remarkable progress in recent years, owing to technological advancements and research breakthroughs. Improved diagnostic techniques enable early and accurate cancer detection, empowering veterinarians to initiate timely treatment. Moreover, the rise in understanding of cancer biology in pets has opened doors to targeted therapies, immunotherapies, and novel treatment modalities. Veterinary oncologists now have an expanded toolbox of cancer treatments, facilitating the development of personalized care plans tailored to each pet's unique condition. These advancements instill hope in pet owners facing a cancer diagnosis for their beloved animals and encourage them to explore and opt for advanced and effective cancer therapies.

Growing veterinary healthcare expenditure

The changing perception of pets from mere animal companions to valued family members has led to a notable shift in spending patterns on veterinary healthcare. Pet owners today are more willing than ever to allocate substantial financial resources to ensure their pets' well-being and longevity. The growing awareness of available cancer treatment options and the desire to provide the best possible care have driven the increase in expenditure on pet cancer therapeutics. Owners are willing to invest in the latest and most effective cancer treatments to combat the disease and improve the overall health and happiness of their furry companions. This surge in veterinary healthcare spending further propels the pet cancer therapeutics market, creating opportunities for research, innovation, and the development of advanced cancer treatment options for pets.

Pet Cancer Therapeutics Industry Segmentation:

The publisher provides an analysis of the key trends in each segment of the global pet cancer therapeutics market report, along with forecasts at the global, regional and country levels from 2026-2034. Our report has categorized the market based on therapy, animal species, cancer type and end user.

Breakup by Therapy:

  • Chemotherapy
  • Radiation Therapy
  • Immunotherapy
  • Combination Therapy
  • Others

Chemotherapy dominates the market

Chemotherapy is widely used as a standard treatment for various types of pet cancers. As a potent and systematic approach, chemotherapy targets rapidly dividing cancer cells, inhibiting their growth and spread. Its ability to treat a wide range of cancers, including lymphoma, mast cell tumors, and osteosarcoma, makes it a versatile and essential therapeutic option for veterinary oncologists.

Moreover, advancements in veterinary medicine have led to the development of more targeted and less toxic chemotherapy regimens, reducing adverse effects and improving the overall quality of life for pets undergoing treatment. The increasing prevalence of pet cancer cases, coupled with the growing awareness among pet owners about available treatment options, further contributes to the expansion of the chemotherapy segment.

Breakup by Animal Species:

  • Cats
  • Dogs
  • Others

Dogs hold the largest share in the market

Dogs have a higher susceptibility to various types of cancers, mirroring human conditions. As a popular companion animal, dogs are commonly affected by cancers such as lymphoma, melanoma, and mammary tumors, among others. The similarities in cancer biology and tumor types between dogs and humans make dogs valuable models for studying cancer treatments, leading to advancements in therapeutic approaches that benefit both species. Veterinary oncology research conducted in dogs has resulted in the development of targeted therapies, immunotherapies, and novel treatment modalities that can be translated to human medicine. Furthermore, the strong emotional bond between pet owners and their dogs fosters a willingness to invest in their healthcare, including cancer treatments, thus driving the demand for effective pet cancer therapeutics.

Breakup by Cancer Type:

  • Lymphoma
  • Mast Cell Cancer
  • Melanoma
  • Mammary and Squamous Cell Cancer
  • Others

Mast cell cancer represents the most popular type of cancer

Mast cell tumors are one of the most common skin cancers in dogs, affecting various breeds and age groups. Their diverse behavior and variable response to treatments necessitate specialized therapeutics for effective management. Veterinary oncologists are continually researching and developing targeted therapies and immunotherapies specifically tailored to combat mast cell cancer. As a result, advancements in pet cancer therapeutics for mast cell tumors benefit dogs as well as contribute to the broader understanding and treatment of mast cell-related conditions in humans. The increasing awareness among pet owners about the need for early detection and comprehensive treatment options further drives the demand for innovative and efficient pet cancer therapeutics.

Breakup by End User:

  • Veterinary Hospitals and Clinical Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Veterinary hospitals and clinical pharmacies account for the largest market share

Veterinary hospitals and clinical pharmacies play a crucial role in driving the pet cancer therapeutics market by serving as key distribution and treatment centers for specialized pet cancer drugs and therapies. These institutions provide a centralized platform for pet owners to access a wide range of cancer treatments, including chemotherapy agents, targeted therapies, and immunotherapies. Veterinary hospitals collaborate with pharmaceutical companies and research institutions to stay updated on the latest advancements in pet cancer therapeutics, offering cutting-edge treatment options to their patients. Clinical pharmacies within these facilities ensure accurate drug dispensing and administration, adhering to precise dosages and treatment protocols. Their expertise in handling pet cancer therapeutics and providing personalized care contributes to improved treatment outcomes and enhances pet owners' confidence in seeking optimal cancer care for their beloved animal companions, ultimately driving the growth of the pet cancer therapeutics market.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and Others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and Others) Latin America (Brazil, Mexico and Others), Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest share in the market since the region has a high prevalence of pet ownership, and there is a strong bond between pet owners and their animals, leading to a greater willingness to invest in their healthcare, including cancer treatment. North America is also at the forefront of advancements in veterinary medicine and oncology research, resulting in the development of innovative and targeted pet cancer therapeutics. Veterinary hospitals and research institutions in the region collaborate closely with pharmaceutical companies to conduct clinical trials and introduce cutting-edge treatments to the market. Additionally, the presence of well-established veterinary healthcare infrastructure and a growing trend of personalized pet care contribute to the demand for specialized and effective cancer therapies. These factors collectively drive the growth of the market for pet cancer therapeutics in North America, making it a leading region in the industry.

Competitive Landscape:

The market is experiencing steady growth in recent years as various key players are focusing on the development of targeted therapies and immunotherapies tailored to specific types of pet cancers, aiming to enhance treatment effectiveness and reduce side effects. Numerous advancements in precision medicine by leading players have led to the identification of genetic and molecular biomarkers, allowing for personalized treatment approaches. Additionally, novel drug delivery methods, such as nanoparticles and liposomes, are being explored by manufacturers to improve drug stability and enhance tumor penetration. The integration of emerging technologies like artificial intelligence (AI) and machine learning (ML) in pet cancer research is revolutionizing data analysis and accelerating drug discovery processes. We also expect the market to witness new entrants, consolidation of product portfolios, rise in research and development (R&D) initiatives, and increased strategic collaborations to drive healthy competition within the pet cancer therapeutics domain.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • AB Science
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • ELIAS Animal Health LLC
  • Karyopharm Therapeutics
  • Pfizer Inc.
  • Regeneus Ltd.
  • Rhizen Pharmaceuticals AG
  • Torigen Pharmaceuticals Inc.
  • VetDC Inc.
  • Virbac
  • Zoetis Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global pet cancer therapeutics market in 2025?
  • 2.What is the expected growth rate of the global pet cancer therapeutics market during 2026-2034?
  • 3.What are the key factors driving the global pet cancer therapeutics market?
  • 4.What has been the impact of COVID-19 on the global pet cancer therapeutics market?
  • 5.What is the breakup of the global pet cancer therapeutics market based on the therapy?
  • 6.What is the breakup of the global pet cancer therapeutics market based on thej animal species?
  • 7.What is the breakup of the global pet cancer therapeutics market based on cancer type?
  • 8.What is the breakup of the global pet cancer therapeutics market based on the end user?
  • 9.What are the key regions in the global pet cancer therapeutics market?
  • 10.Who are the key players/companies in the global pet cancer therapeutics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pet Cancer Therapeutics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Therapy

  • 6.1 Chemotherapy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Radiation Therapy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Immunotherapy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Combination Therapy
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Animal Species

  • 7.1 Cats
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Dogs
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Cancer Type

  • 8.1 Lymphoma
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Mast Cell Cancer
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Melanoma
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Mammary and Squamous Cell Cancer
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Veterinary Hospitals and Clinical Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AB Science
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 Boehringer Ingelheim International GmbH
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 Elanco Animal Health Incorporated
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 ELIAS Animal Health LLC
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Karyopharm Therapeutics
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Pfizer Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Regeneus Ltd.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Rhizen Pharmaceuticals AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Torigen Pharmaceuticals Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 VetDC Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Virbac
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Zoetis Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2020-2025
  • Figure 2: Global: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 3: Global: Pet Cancer Therapeutics Market: Breakup by Therapy (in %), 2025
  • Figure 4: Global: Pet Cancer Therapeutics Market: Breakup by Animal Species (in %), 2025
  • Figure 5: Global: Pet Cancer Therapeutics Market: Breakup by Cancer Type (in %), 2025
  • Figure 6: Global: Pet Cancer Therapeutics Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Pet Cancer Therapeutics Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Pet Cancer Therapeutics (Chemotherapy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Pet Cancer Therapeutics (Chemotherapy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Pet Cancer Therapeutics (Radiation Therapy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Pet Cancer Therapeutics (Radiation Therapy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Pet Cancer Therapeutics (Immunotherapy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Pet Cancer Therapeutics (Immunotherapy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Pet Cancer Therapeutics (Combination Therapy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Pet Cancer Therapeutics (Combination Therapy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Pet Cancer Therapeutics (Other Therapies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Pet Cancer Therapeutics (Other Therapies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Pet Cancer Therapeutics (Cats) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Pet Cancer Therapeutics (Cats) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Pet Cancer Therapeutics (Dogs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Pet Cancer Therapeutics (Dogs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Pet Cancer Therapeutics (Other Animal Species) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Pet Cancer Therapeutics (Other Animal Species) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Pet Cancer Therapeutics (Lymphoma) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Pet Cancer Therapeutics (Lymphoma) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Pet Cancer Therapeutics (Mast Cell Cancer) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Pet Cancer Therapeutics (Mast Cell Cancer) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Pet Cancer Therapeutics (Melanoma) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Pet Cancer Therapeutics (Melanoma) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Pet Cancer Therapeutics (Mammary and Squamous Cell Cancer) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Pet Cancer Therapeutics (Mammary and Squamous Cell Cancer) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Pet Cancer Therapeutics (Other Cancer Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Pet Cancer Therapeutics (Other Cancer Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Pet Cancer Therapeutics (Veterinary Hospitals and Clinical Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Pet Cancer Therapeutics (Veterinary Hospitals and Clinical Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Global: Pet Cancer Therapeutics (Retail Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Global: Pet Cancer Therapeutics (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Global: Pet Cancer Therapeutics (Online Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Global: Pet Cancer Therapeutics (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Global: Pet Cancer Therapeutics (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Global: Pet Cancer Therapeutics (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: North America: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: North America: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: United States: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: United States: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Canada: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Canada: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Asia-Pacific: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Asia-Pacific: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: China: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: China: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Japan: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Japan: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: India: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: India: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: South Korea: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: South Korea: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Australia: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Australia: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Indonesia: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Indonesia: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Others: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Others: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Europe: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Europe: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Germany: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Germany: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: France: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: France: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: United Kingdom: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: United Kingdom: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Italy: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Italy: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Spain: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Spain: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Russia: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Russia: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Others: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Others: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Latin America: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Latin America: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Brazil: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Brazil: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Mexico: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 85: Mexico: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 86: Others: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 87: Others: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 88: Middle East and Africa: Pet Cancer Therapeutics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 89: Middle East and Africa: Pet Cancer Therapeutics Market: Breakup by Country (in %), 2025
  • Figure 90: Middle East and Africa: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 91: Global: Pet Cancer Therapeutics Industry: SWOT Analysis
  • Figure 92: Global: Pet Cancer Therapeutics Industry: Value Chain Analysis
  • Figure 93: Global: Pet Cancer Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pet Cancer Therapeutics Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Pet Cancer Therapeutics Market Forecast: Breakup by Therapy (in Million USD), 2026-2034
  • Table 3: Global: Pet Cancer Therapeutics Market Forecast: Breakup by Animal Species (in Million USD), 2026-2034
  • Table 4: Global: Pet Cancer Therapeutics Market Forecast: Breakup by Cancer Type (in Million USD), 2026-2034
  • Table 5: Global: Pet Cancer Therapeutics Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 6: Global: Pet Cancer Therapeutics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Pet Cancer Therapeutics Market: Competitive Structure
  • Table 8: Global: Pet Cancer Therapeutics Market: Key Players